The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action
Description: This report focuses on the U.S. Food and Drug Administration (FDA) as a key player in federal efforts to curb the opioid epidemic. It provides an overview of FDA's role in approving new prescription drugs, including challenges of approval and regulation of opioid products; addresses FDA's multifaceted approach in responding, including recent agency action; and concludes with a discussion of selected opioid-related legislation in the 115th Congress.
Date: June 5, 2018
Creator: Staman, Jennifer A.
Partner: UNT Libraries Government Documents Department